Your browser doesn't support javascript.
loading
Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.
Berera, Shivali; Ioannou, Stephanie C; Morillo, Diana; Mantero, Alejandro M A; Pignac-Kobinger, Judith; Colina, Niurka; Santander, Ana M; Fernandez, Irina; Quintero, Maria Alejandra; Rodriguez, Jennifer; Kerman, David H; Damas, Oriana M; Czul, Frank; Sussman, Daniel A; Abreu, Maria T; Deshpande, Amar R.
Afiliación
  • Berera S; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Ioannou SC; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Morillo D; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Mantero AMA; Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Pignac-Kobinger J; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Colina N; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Santander AM; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Fernandez I; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Quintero MA; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Rodriguez J; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Kerman DH; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Damas OM; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Czul F; Division of Gastroenterology, Mount Sinai Medical Center, Miami Beach, FL, USA.
  • Sussman DA; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Abreu MT; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Deshpande AR; Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
J Crohns Colitis ; 16(11): 1687-1695, 2022 Nov 23.
Article en En | MEDLINE | ID: mdl-35642747
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Asunto principal: Pentoxifilina / Enfermedad de Crohn Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Asunto principal: Pentoxifilina / Enfermedad de Crohn Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos